6505--PHARMACY-CHEMO COMPOUNDING
ID: 36C24224Q0819Type: Sources Sought
Overview

Buyer

VETERANS AFFAIRS, DEPARTMENT OFVETERANS AFFAIRS, DEPARTMENT OF242-NETWORK CONTRACT OFFICE 02 (36C242)ALBANY, NY, 12208, USA

NAICS

Pharmaceutical Preparation Manufacturing (325412)

PSC

DRUGS AND BIOLOGICALS (6505)

Original Source

https://sam.gov/opp/e4de89f7f568401f8ba8be2af5c66837/view
Timeline
    Description

    The Department of Veterans Affairs (VA) Network Contracting Office 2 intends to award a sole source contract to Optum Pharmacy for the provision of chemotherapy services at the New Jersey Veterans Affairs Medical Center (NJ VAMC). This contract is necessitated by current limitations in local compounding of hazardous medications and will cover one base year with four optional years. The contractor is required to ensure compliance with drug stability during shipping, timely delivery of chemotherapy products by 10:30 AM on treatment days, adherence to aseptic preparation techniques in accordance with USP 797 and USP 800 regulations, and compatibility with specific medical equipment. Interested firms that believe they can meet these requirements must submit written notifications by September 12, 2024, at 9:00 AM ET via email to Lee Kern at Lee.Kern@va.gov, as telephone inquiries will not be accepted.

    Point(s) of Contact
    Lee KernContract Specialist
    (607) 664-4748
    Lee.Kern@va.gov
    Files
    Title
    Posted
    36C24224Q0819_1.docx
    The Department of Veterans Affairs (VA) Network Contracting Office 2 intends to award a sole source contract to Optum Pharmacy for chemotherapy provision at the New Jersey Veterans Affairs Medical Center (NJ VAMC) due to current limitations in local compounding of hazardous medications. This contract will cover one base year with four optional years. Key deliverables include compliance with drug stability requirements for shipping, timely delivery of chemotherapy products, adherence to aseptic preparation techniques following USP 797 and USP 800 regulations, and compatibility with specific medical equipment. Despite being a sole source notice, firms can respond if they can meet these requirements before the September 12, 2024 deadline. Responses must be submitted via email, with no telephonic inquiries allowed. This document underscores the VA's commitment to ensuring continuous chemotherapy services while adhering to safety and regulatory standards.
    Lifecycle
    Title
    Type
    6505--PHARMACY-CHEMO COMPOUNDING
    Currently viewing
    Sources Sought
    Similar Opportunities
    6505--760_Pharmaceuticals_VA CMOP Leavenworth_36C77024Q0344
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is announcing a special notice regarding the awarding of contracts under Solicitation Number 36C77024Q0344, specifically for pharmaceutical services through the National CMOP Contracting Office. This procurement has resulted in two awards totaling $157,961.04, granted to Core Trading Company and Pharmacy Buying Association, Inc., for various line items related to pharmaceutical preparation. The awarded contracts are part of the government's ongoing efforts to efficiently procure necessary pharmaceutical services for veterans. Interested parties should contact Contracting Specialist Jeffrey Blackard at jeffrey.blackard@va.gov or call 913-684-1042, with submissions due by September 18, 2024, at 10 PM Central Time.
    6505--Notice of Intent to Sole Source Pluvicto and Lutathera
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) intends to award a sole source contract to Advanced Accelerator Applications USA for the provision of Pluvicto and Lutathera, specialized radiopharmaceuticals used in the treatment of metastatic castration-resistant prostate cancer and gastroenteropancreatic neuroendocrine tumors. This procurement is justified under FAR regulations due to the unique and highly specialized nature of the therapies required, which limits the availability of suitable suppliers. Interested parties are invited to submit their capability statements, including qualifications and relevant contract information, by 10:00 AM PT on September 25, 2024, to Peter Kim at peter.kim33@va.gov. The contracting office is located in Long Beach, CA, and responses must be submitted electronically; failure to respond may result in the contract being awarded without further solicitation.
    6505--Lymphoseek IDIQ
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs, specifically the Network Contracting Office 22, intends to award a Sole Source contract for the procurement of Lymphoseek, a proprietary radiopharmaceutical, primarily for use at the VA Loma Linda Healthcare System. This contract, designated as Solicitation Number 36C26225Q0026, will be structured as a Firm Fixed-Price Indefinite Quantity Indefinite Delivery (IDIQ) with a base year and four option years, with an estimated quantity of 86 study doses required annually. Lymphoseek is critical for identifying sentinel lymph nodes in melanoma patients, providing superior image quality due to its targeted action on the CD206 receptor. Interested parties may submit a capabilities statement by September 27, 2024, at 10:00 AM Pacific Time, and should direct inquiries to Hestia Sim at Hestia.Sim@va.gov.
    J065--INTENT TO SOLE SOURCE OMNICELL PHARMACY EQUIPMENT PM&R
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) intends to award a sole-source contract for preventive maintenance of OMNICELL pharmacy equipment and Omni Center Server software, specifically at the Phoenix VA Medical Center. This procurement is necessary to ensure the ongoing functionality and reliability of critical pharmacy equipment, which plays a vital role in the healthcare services provided to veterans. Interested vendors must submit capability statements demonstrating relevant past performance and licensing status by 12:00 PM Pacific Time on September 20, 2024, and should direct inquiries to Contract Specialist Charity Cazee at charity.cazee@va.gov.
    J065--Arxium Pharmacy Optifill Preventative Maintenance Base + 1
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs intends to award a sole-source contract to ARxIUM, Inc. for preventative maintenance and technical support services for ARxIUM equipment at the VA Pacific Island Health Care System. The contract will provide 24/7 technical support and maintenance, with a total estimated value of up to $250,873.88 for a base year and one optional year, covering the period from October 1, 2024, to September 30, 2025. This procurement is justified under U.S.C. 253(c)(1) as ARxIUM's services are deemed to best meet the Government's needs, and interested vendors must demonstrate their authorization to perform these services by responding by September 23, 2024, at 1:00 PM Pacific Standard Time. For further inquiries, interested parties may contact Contract Specialist Durell Salaz at durell.salaz@va.gov or by phone at 209-304-5880.
    W065--Pharmacy Sterile Compounding Trailer - Lease
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs, through the Network Contracting Office 22, is seeking to lease a Pharmacy Sterile Compounding Trailer for the VA Long Beach Healthcare System in California. The procurement aims to provide a mobile cleanroom system compliant with USP 797 and USP 800 standards, essential for the safe preparation of hazardous and non-hazardous drugs. This initiative supports the VA's commitment to enhancing pharmaceutical services for veterans, ensuring compliance with stringent safety and operational guidelines. Interested vendors, particularly Service-Disabled Veteran-Owned Small Businesses, must submit their proposals by September 3, 2024, with inquiries directed to Contracting Officer Anthony Dela Cruz at anthony.delacruz@va.gov or by phone at 562-766-2284.
    6505--Supply, Axumin-Axumin + Cerianna Medicines - Nuclear Med, CLE
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs intends to solicit and negotiate exclusively with PetNet Solutions and TrillaMed for the supply of three proprietary radiopharmaceuticals—Axumin, Amyvid, and Cerianna—for the Nuclear Medicine Service at the Louis Stokes Cleveland VA Medical Center. These products are critical for diagnosing recurrent prostate cancer, breast cancer, and Alzheimer’s disease, necessitating the use of a local radiopharmacy due to their radioactive nature and short shelf life. Interested vendors may submit their capabilities until September 18, 2024, to determine if a competitive procurement process is feasible, with all inquiries directed to Contract Specialist Don Caldwell at don.caldwell@va.gov.
    H399--DSS VISTA CHEMOTHERAPY SOFTWARE
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs, Network Contracting Office (NCO) 16, intends to issue a sole-source contract for VISTA Chemotherapy Software services with Document Storage Systems, Inc. (DSS). The contract aims to ensure the software's optimal functionality at the Southeast Louisiana Veterans Health Care System for a base period of six months, with an option for an additional six-month extension. This procurement is critical as DSS is identified as the only viable provider due to the unique characteristics of the software required for effective operation. Interested parties must submit their capabilities statements by October 1, 2024, to Marcus Sidney at marcus.sidney@va.gov, and must be registered with the System for Award Management (SAM) to be eligible for the contract.
    Q527--Intent to Sole Source Radiopharm Isotopes-Wilkes-Barre VAMC
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs, through Network Contracting Office 4, intends to issue a sole source contract for the provision of Radiopharmaceutical Isotopes to the Wilkes-Barre VA Medical Center, specifically with Jubilant Draximage Radiopharmaceuticals Inc. The contract aims to ensure the timely delivery of radiopharmaceuticals that comply with U.S. Nuclear Regulatory Commission (NRC) and Food and Drug Administration (FDA) regulations, thereby prioritizing patient safety and effective healthcare for veterans. This procurement is critical for maintaining high-quality medical services, as the contractor will be required to adhere to strict quality control measures, provide emergency services, and ensure proper packaging and labeling of all materials supplied. Interested vendors must submit a capability statement by September 20, 2024, to the Contracting Specialist, Christa Stine, at christa.stine@va.gov.
    Q522--PHARMACUTICAL, STL 657-24-3-1642-0121, (VA-25-00001168)
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking responses to a Sources Sought Notice for a contract involving the provision of a proprietary radiopharmaceutical agent, Pluvicto, for the St. Louis VA Medical Center. This contract will cover a base year plus four option years for the supply of Lutetium LU 177 Vipivvotide Tetraxetan, which is critical for treating adult patients with prostate-specific membrane antigen (PSMA) positive metastatic castration-resistant prostate cancer. The selected contractor will be responsible for administering this radioactive diagnostic therapy via IV, with all contract administration functions retained by the Department of Veterans Affairs. Interested parties must submit their responses by September 20, 2024, at 3:00 PM CST, to Michael P. Murphy at michael.murphy7@va.gov, including their Unique Entity ID and relevant qualifications.